Ribavirin Injection 200mg/2ml / High Quality

• Customization: Available
• Packaging From: 10 Ampoules/Box
• Packaging: Customization
• Model NO.: injection
• Dosage: Ready
• Transport Package: Shipping
• Specification: 2ml: 200mg
• Trademark: brand
• Origin: China

Product Description

Value-added services:
 1) Packaging design by our team
 2) Registration service by our team
 3) Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ribavirin Injection 200mg/2mL (100 mg/mL)

Composition:

Each 2mL ampoule contains:

• Ribavirin - 200 mg (100 mg/mL)
• Excipients: Sodium chloride, Water for injection

Description:

Ribavirin is a broad-spectrum antiviral drug that inhibits viral RNA synthesis and replication. It is used in the treatment of severe viral infections, particularly those caused by hepatitis C virus (HCV) and respiratory syncytial virus (RSV).

Indications:

Ribavirin Injection is indicated for:

• Chronic Hepatitis C Virus (HCV) infection (in combination with interferon therapy)
• Severe Respiratory Syncytial Virus (RSV) infections
• Hemorrhagic fevers caused by Arenaviruses (e.g., Lassa fever)

Dosage & Administration:

Chronic Hepatitis C (with Interferon α-2b):

• Adults: 1,000-1,200 mg/day (divided into 2 doses)
• Duration: 24-48 weeks depending on genotype

Respiratory Syncytial Virus (RSV) Infection:

• Aerosolized therapy: 20 mg/mL solution administered via nebulizer for 12-18 hours/day for 3-7 days
• IV therapy (severe cases): 15-20 mg/kg/day divided into 3 doses for 5-7 days

Hemorrhagic Fever (Lassa Fever, Arenavirus Infections):

• Loading dose: 30 mg/kg IV
• Maintenance dose: 15 mg/kg IV every 6 hours for 4 days, then 7.5 mg/kg every 8 hours for 6 days

Administration:

• IV infusion: Administer slowly over 30-60 minutes
• Do not mix with other medications in the same IV line

Contraindications:

• Hypersensitivity to Ribavirin
• Pregnancy (Category X - teratogenic)
• Severe renal impairment (CrCl <50 mL/min)
• Hemoglobinopathies (e.g., Thalassemia, Sickle cell anemia)

Precautions:

• Avoid pregnancy during and 6 months after treatment (use contraception)
• Monitor hemoglobin levels (risk of hemolytic anemia)
• Use caution in patients with cardiovascular disease

Adverse Reactions:

• Common: Fatigue, nausea, headache, anemia, insomnia
• Serious: Hemolytic anemia, liver toxicity, depression, teratogenic effects

Drug Interactions:

• Didanosine (HIV treatment): Increased toxicity risk
• Azathioprine: Increased risk of bone marrow suppression
• Interferon α-2b: Increased effectiveness but higher side effects

Overdose & Management:

• Symptoms: Severe anemia, nausea, confusion
• Treatment: Supportive care, discontinue if hemoglobin <8.5 g/dL

Storage Conditions:

• Store below 25°C
• Protect from light
• Do not refrigerate or freeze